Cherry is a life science strategy consultant with experience in competitive intelligence, drug life cycle management, market opportunity assessment and asset valuation. Prior to joining Bluestar, Cherry was the Director of Product Management at a digital healthcare company specializing in product opportunity assessment and asset valuation in the pediatric healthcare market. She also has extensive knowledge in oncology having worked at Eli Lilly in the R&D group. Cherry received a Ph.D. in Chemical Engineering from Columbia University, and a B.Sc in Chemical and Biological Engineering from New York University. She is also fluent in Mandarin.